Our client was responsible for developing strategy for their pre-clinical portfolio of drugs in Rheumatoid Arthritis. They already had a set of Insight opportunity areas, previously developed for a pre-launch brand, along with new data and experience from the market. They wanted to ensure this new learning was built into their Insight Platforms and, importantly, indicate potential impact directly into their therapy strategy.
TIGCRU designed and facilitated pre-work and a one day workshop to look with ‘fresh eyes’ at the data and experience the team had gained. From this fresh look, we derived opportunity areas and then considered these against the existing disease area strategy. We added richness to the direction currently being taken, and identified gaps to be re-considered.
The outcome of the workshop was a set of insight enriched Disease Area Target Product Profiles.